Injective vs Mantra — how do they compare? Injective trades at Rp91,720 (market cap Rp9,12T, Rp2T 24h volume), while Mantra trades at Rp117.07 (market cap Rp619,92M, Rp136,24M 24h volume). The key difference: Injective is far larger — about 14711.6× Mantra's market cap, and Mantra's supply is capped (5,4B / 10B MANTRA (55%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Mantra for 21 Days on average.
| INJ | MANTRA | |
|---|---|---|
Market Cap | Rp9,12T | Rp619,92M |
Volume (24h) | Rp2T | Rp136,24M |
Circulating Supply | 100M INJ | 5,4B / 10B MANTRA (55%) |
Typical Hold Time | 36 Days | 21 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp91,720, showing bullish technical signals with strong moving average support. The asset holds a market cap of Rp9.12 trillion, with key resistance at Rp95,079 and support at Rp89,584. RSI levels indicate mild overbought conditions, while the neutral oscillators suggest consolidation. Recent ecosystem growth includes protocol upgrades and increased DeFi activity, though no major news is currently driving momentum.
Overall outlook is cautiously optimistic with technical strength, but investors should monitor overbought RSI risks and broader crypto market volatility. Key opportunities lie in network adoption and DeFi integration, while major risks include regulatory uncertainty and liquidity fluctuations typical of altcoins.
MANTRA is currently trading at Rp113.766 with a market cap of Rp613.49M, showing bearish technical signals with 15 sell indicators versus 1 buy. The token is trading near its pivot point of Rp114, with immediate support at Rp111 and resistance at Rp118. With 55% of the 10M max supply in circulation and average hold time of 21 days, the asset shows moderate distribution. No recent protocol updates or ecosystem developments were identified.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential oversold conditions (RSI_6 at 28.78 suggests buying opportunity) while major risks include limited liquidity and the prevailing bearish trend. Investors should monitor support levels closely for potential entry points.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →MANTRA is a compliance-oriented Layer 1 blockchain built to tokenize and manage real-world assets within a regulated framework. Designed for institutional use, it enables assets like real estate to be brought on-chain with embedded legal and regulatory controls. The network is EVM-compatible, allowing developers to use familiar Ethereum tools while leveraging custom compliance features.
Read more on MANTRA →